Samsung Bioepis Receives Positive CHMP Opinion for Eculizumab Biosimilar, EPYSQLI™
<!-- Name:DistributionId Value:8799603 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Eculizumab
Samsung Bioepis Presents New Phase 3 Study of SB12 (Eculizumab), A Proposed…
Phase 3 study demonstrated clinical equivalence in efficacy, safety, pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity of SB12 compared to reference eculizumab in paroxysmal…
Myasthenia Gravis: Better Version of Eculizumab on the Horizon
SEATTLE -- An agent that works similarly to the approved myasthenia gravis (MG) drug eculizumab (Soliris) but with a longer dosing…